Drug-labels.com

Apo-Riluzole: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
50 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Riluzole

ABOUT THIS MEDICATION

What the medication is used for:

The treatment of amyotrophic lateral sclerosis (ALS), a disease of the brain and spinal cord that causes muscle weakness and wasting, and eventually paralysis.

What it does:

APO-RILUZOLE is not a cure for ALS; although it may prolong life by an average time of about 3 months.

There is no evidence that APO-RILUZOLE has an effect on the symptoms of ALS, so you are not likely to feel a difference or see a noticeable change in your condition during treatment.

When it should not be used:

  • if you have liver problems
  • if you have an allergy or sensitivity to riluzole or

    any of the other tablet ingredients (See “What the nonmedicinal ingredients are” in this section)

  • If you are pregnant or breastfeeding

What the medicinal ingredient is:

riluzole

What the important nonmedicinal ingredients are:

croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, talc and titanium dioxide.

What dosage forms it comes in:

Film coated tablets, 50 mg

WARNINGS AND PRECAUTIONS

Some people may experience liver injury while taking APO-RILUZOLE that is most often mild and temporary. Your doctor should periodically test the function of your liver while you are taking APO-RILUZOLE. Depending on these tests results, your doctor may decide that additional liver evaluation is required.

Signs of liver injury for patients to watch for are listed in the section “SIDE EFFECTS AND WHAT TO DO ABOUT THEM”

BEFORE you use APO-RILUZOLE talk to your doctor or pharmacist if: you have ever had any allergic reactions to medications, food etc.

  • you have liver problems
  • you are taking other drugs that may be toxic to the liver
  • you are or think you are pregnant or if you may become pregnant
  • you are breastfeeding

Because APO-RILUZOLE can, rarely, decrease white blood cells counts, let your doctor know if you experience fever, so the decision can be made as to whether further investigation is needed.

APO-RILUZOLE may make you to feel dizzy or sleepy. If you experience these feelings do not drive a vehicle or use machinery.

APO-RILUZOLE must not be given to anyone other than the person for whom it was prescribed.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with APO-RILUZOLE include:

  • Drugs that may be toxic to the liver, such as allopurinol, methyldopa or sulfasalazine.
  • Drugs or substances that may have an effect on the elimination of APO-RILUZOLE from the body, such as caffeine, the antibiotics quinolones and rifampicin, theophylline, amitriptyline, omeprazole, cigarette smoke and charcoal-broiled food.

PROPER USE OF THIS MEDICATION

Usual dose:

The effect of APO-RILUZOLE therapy is dependent upon taking it continuously at regular intervals, as directed. It is important that you follow your doctor’s instructions about taking APO-RILUZOLE.

The recommended dose is 1 tablet (50 mg) every 12 hours.

APO-RILUZOLE should be taken 1 hour before meals or 2 hours after meals. You should take this medicine on a regular basis and at the same time of the day (e.g., in the morning and evening) each day.

Overdose:

There is no benefit in increasing the dose above two tablets per day. In fact, you may experience more side effects. Any medication taken in excess can have serious consequences.

If you have taken too much APO-RILUZOLE, immediately see your doctor or go to your nearest hospital emergency department. Show the doctor your bottle of tablets. Do this even if there are no signs of discomfort or poisoning.

In the event of overdosage, contact your doctor,
hospital emergency department or regional Poison
Control Centre Immediately.

Missed Dose:

If you miss or skip a dose of APO-RILUZOLE, take your medicine at the next scheduled time. Do not take any extra tablets to make up for those you missed.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are mild, temporary liver injury, weakness, fatigue, dizziness and stomach upset. Some less common side effects are: vomiting, mouth sores, increase or loss of appetite, eczema, diarrhea, irregular or fast heart beat and swelling of the hands, feet or legs. APO-RILUZOLE may have other side effects which have not been described here. If you notice any change in your health while taking APO-RILUZOLE, tell your doctor.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmaci st
Only if severeIn all case s
CommonDizziness√
Fatigue√
Stomach upset√
Weakness√
Uncommo nDepressed mood√
Diarrhea√
Eczema√
Fever√
Irregular or fast heart beat√
Loss of appetite√
Mouth sores√
Signs of possible liver problems (with symptoms such as: dark urine, a yellow discoloring of the skin or sclera (the white of your eye), itchiness, nausea, vomiting, loss of appetite, general discomfort, tiredness, or abdominal swelling)√
Swelling of hands, feet or legs√
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM

Symptom / effect

Vomiting

Respiratory problems (dry cough, and/or difficulty in breathing)

Talk with your doctor or pharmacist

Stop taking drug and call your doctor or pharmaci

st

Only if severeIn all case s
√
√

This is not a complete list of side effects. For any unexpected effects while taking APO-RILUZOLE, contact your doctor or pharmacist.

HOW TO STORE IT

APO-RILUZOLE should be stored at room temperature (15 to 30°C) and protected from light.

APO-RILUZOLE must be kept out of the reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at

    www.healthcanada.gc.ca/medeffect

  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

For more information, please contact your doctor, pharmacist or other healthcare professional. This leaflet plus the full product monograph, prepared for health professionals, can be obtained by contacting DISpedia, Apotex's Drug Information Service at:

1-800-667-4708

This leaflet can also be found at:

http://www.apotex.ca/products.

M9L 1T9.

Last revised: July 9, 2012

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02352583

Revision date stated in the text: July 9, 2012

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Riluzole

Rx or OTC
Prescription (Rx)?
DIN 02352583
Schedule(s) PRESCRIPTION
Active ingredient(s) Riluzole 50 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07X Other nervous system drugs
        1. N07XX Other nervous system drugs
          1. N07XX02 Riluzole
Company APOTEX INC
Current status Marketed
Current status date September 23, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.